PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

Title
PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume -, Issue -, Pages 203
Publisher
Dove Medical Press Ltd.
Online
2016-01-08
DOI
10.2147/ott.s89967

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started